Murad Melhem

865 total citations
35 papers, 600 citations indexed

About

Murad Melhem is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Nephrology. According to data from OpenAlex, Murad Melhem has authored 35 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 7 papers in Nephrology. Recurrent topics in Murad Melhem's work include Vascular Procedures and Complications (7 papers), Central Venous Catheters and Hemodialysis (7 papers) and Parathyroid Disorders and Treatments (6 papers). Murad Melhem is often cited by papers focused on Vascular Procedures and Complications (7 papers), Central Venous Catheters and Hemodialysis (7 papers) and Parathyroid Disorders and Treatments (6 papers). Murad Melhem collaborates with scholars based in United States, Belgium and United Kingdom. Murad Melhem's co-authors include Pankaj B. Desai, Prabir Roy‐Chaudhury, Sue C. Heffelfinger, Burnett S. Kelly, Jinsong Li, Rino Munda, Heather J. Duncan, Jianhua Zhang, Juan José Pérez Ruixo and Jianhua Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Murad Melhem

34 papers receiving 571 citations

Peers

Countries citing papers authored by Murad Melhem

Since Specialization

Citations

This map shows the geographic impact of Murad Melhem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murad Melhem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murad Melhem more than expected).

Fields of papers citing papers by Murad Melhem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murad Melhem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murad Melhem. The network helps show where Murad Melhem may publish in the future.

Co-authorship network of co-authors of Murad Melhem

This figure shows the co-authorship network connecting the top 25 collaborators of Murad Melhem. A scholar is included among the top collaborators of Murad Melhem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murad Melhem. Murad Melhem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tutorial on Conditional Simulations With a Tumor Size‐Overall Survival Model to Support Oncology Drug Development 2025 ·CPT Pharmacometrics & Systems Pharmacology ·Sebastiaan C. Goulooze, Morris Muliaditan, (unknown), Alejandro Mantero, Sandra A. G. Visser, Murad Melhem, (unknown), Chetan Rathi, Herbert Struemper	1
2	Development of a Joint Tumor Size–Overall Survival Modeling and Simulation Framework Supporting Oncology Development Decision‐Making 2025 ·CPT Pharmacometrics & Systems Pharmacology ·Herbert Struemper, Chetan Rathi, Morris Muliaditan, Sebastiaan C. Goulooze, (unknown), Alejandro Mantero, Murad Melhem, (unknown), Sandra A. G. Visser	1
3	P4.11E.28 Pharmacological Comparison of Dostarlimab and Pembrolizumab in Metastatic Non-Small Cell Lung Cancer in PERLA 2024 ·Journal of Thoracic Oncology ·Tanay S. Samant, Herbert Struemper, (unknown), (unknown), Morris Muliaditan, Murad Melhem, (unknown), Matthias Fastenrath, Neda Stjepanovic, (unknown), (unknown), Alejandro Mantero, (unknown), Stefan Zajic, Niranjan Yanamandra, Chan Chung, Gordana Vlahovic	0
4	Dostarlimab, an anti‐programmed death‐1 monoclonal antibody, does not cause QT prolongation in patients with solid tumours: A concentration‐QT analysis 2023 ·British Journal of Clinical Pharmacology ·(unknown), (unknown), Sharon Lu, Murad Melhem	1
5	Quantification of Radiation Injury on Neutropenia and the Link between Absolute Neutrophil Count Time Course and Overall Survival in Nonhuman Primates Treated with G-CSF 2020 ·Pharmaceutical Research ·John M. Harrold, Per Olsson, Isabelle Delor, Philippe Jacqmin, Juan José Pérez Ruixo, (unknown), Sameer Doshi, Andrew Chow, Bingbing Yang, Murad Melhem	8
6	Data standards for model-informed drug development: an ISoP initiative 2018 ·Journal of Pharmacokinetics and Pharmacodynamics ·(unknown), Brian Corrigan, (unknown), Robert Fox, Jill Fiedler‐Kelly, Huan Liu, Murad Melhem, (unknown), (unknown), Jing Su, Maciej J. Swat, Nathan S. Teuscher, (unknown), (unknown), Justin Wilkins	2
7	Receiver Operating Characteristic Analysis and Clinical Trial Simulation to Inform Dose Titration Decisions 2018 ·CPT Pharmacometrics & Systems Pharmacology ·John D. Clements, Juan José Pérez Ruixo, John P. Gibbs, Sameer Doshi, (unknown), Murad Melhem	4
8	Pharmacokinetic–pharmacodynamic modelling of neutrophil response to G‐CSF in healthy subjects and patients with chemotherapy‐induced neutropenia 2018 ·British Journal of Clinical Pharmacology ·Murad Melhem, Isabelle Delor, Juan José Pérez Ruixo, John M. Harrold, Andrew Chow, (unknown), Philippe Jacqmin	17
9	Population Pharmacokinetic and Pharmacodynamic Modeling of Etelcalcetide in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis 2017 ·Clinical Pharmacokinetics ·Ping Chen, (unknown), Benjamin Wu, Per Olsson, John P. Gibbs, Andrew Chow, Murad Melhem	7
10	Drug disposition model of radiolabeled etelcalcetide in patients with chronic kidney disease and secondary hyperparathyroidism on hemodialysis 2017 ·Journal of Pharmacokinetics and Pharmacodynamics ·(unknown), Murad Melhem, Raju Subramanian, Benjamin Wu	4
11	Translation of Central Nervous System Occupancy from Animal Models: Application of Pharmacokinetic/Pharmacodynamic Modeling 2013 ·Journal of Pharmacology and Experimental Therapeutics ·Murad Melhem	10
12	Population Pharmacokinetic Analysis for Hydrocodone Following the Administration of Hydrocodone Bitartrate Extended-Release Capsules 2013 ·Clinical Pharmacokinetics ·Murad Melhem, Christopher M. Rubino, Stephen J. Farr, (unknown)	6
13	Bendamustine pharmacokinetic profile and exposure–response relationships in patients with indolent non-Hodgkin’s lymphoma 2010 ·Cancer Chemotherapy and Pharmacology ·Joel Owen, Murad Melhem, Julie Passarell, Denise D’Andrea, Mona Darwish, (unknown)	47
14	Perivascular paclitaxel wraps block arteriovenous graft stenosis in a pig model 2006 ·Nephrology Dialysis Transplantation ·Burnett S. Kelly, Murad Melhem, Jianhua Zhang, Gerald B. Kasting, Jinsong Li, Mahesh Krishnamoorthy, Sue C. Heffelfinger, (unknown), Pankaj B. Desai, Prabir Roy‐Chaudhury	56
15	Development of a Local Perivascular Paclitaxel Delivery System for Hemodialysis Vascular Access Dysfunction: Polymer Preparation and in vitroActivity 2006 ·Blood Purification ·Murad Melhem, Burnett S. Kelly, Jianhua Zhang, Gerald B. Kasting, Jinsong Li, (unknown), Sue C. Heffelfinger, Pankaj B. Desai, Prabir Roy‐Chaudhury	21
16	In vitro Paclitaxel and Radiation Effects on the Cell Types Responsible for Vascular Stenosis: A Preliminary Analysis 2006 ·Blood Purification ·(unknown), Murad Melhem, (unknown), Burnett S. Kelly, (unknown), Mahesh Krishnamoorthy, Sue C. Heffelfinger, Pankaj B. Desai, Prabir Roy‐Chaudhury	3
17	Vascular Access in Hemodialysis: Issues, Management, and Emerging Concepts 2005 ·Cardiology Clinics ·Prabir Roy‐Chaudhury, Burnett S. Kelly, Murad Melhem, Jianhua Zhang, Jinsong Li, Pankaj B. Desai, Rino Munda, Sue C. Heffelfinger	67
18	Novel Therapies for Hemodialysis Vascular Access Dysfunction: Fact or Fiction! 2004 ·Blood Purification ·Prabir Roy‐Chaudhury, Burnett S. Kelly, Murad Melhem, Jianhua Zhang, Jinsong Li, Pankaj B. Desai, Rino Munda, Sue C. Heffelfinger	17
19	Hemodialysis Vascular Access Dysfunction: From Pathophysiology to Novel Therapies 2003 ·Blood Purification ·Prabir Roy‐Chaudhury, Burnett S. Kelly, Jianhua Zhang, (unknown), Pankaj B. Desai, Murad Melhem, Heather J. Duncan, Sue C. Heffelfinger	83
20	Hemodialysis vascular access dysfunction from basic biology to clinical intervention 2002 ·Advances in Renal Replacement Therapy ·Prabir Roy‐Chaudhury, Burnett S. Kelly, (unknown), Pankaj B. Desai, Murad Melhem, Rino Munda, Heather J. Duncan, Sue C. Heffelfinger	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact